RNRMarketResearch.com

Single-use Bioreactor Market to Grow at a Healthy CAGR of +21% by 2021 The market to hit $1,085.7 Million

Press Release   •   Nov 07, 2016 15:21 EST

The report "Single-use Bioreactor Market by Product (Stem cells, Interferons), Cell (Yeast, Plant cells), Technology (Bubble column bioreactors), Application (R&D, Bioproduction), End User (R&D department, Biopharmaceutical manufacturers) - Global Forecast to 2021", Projects the market to Grow at a CAGR CAGR of +21%. The market to hit $1,085.7 Million by 2021

Factors such as Improved returns on investment for small companies and startups, and reduced complexity of automation are the major factors driving the adoption of single-use bioreactors. On the other hand, regulatory concerns related to SUBs and issues regarding leachables and extractables are the major factors restraining the growth of this market.

Browse 115 market data Tables and 55 Figures spread through 148 Pages and in-depth TOC on "Single-use Bioreactor Market by Product (Stem cells, Interferons), Cell (Yeast, Plant cells), Technology (Bubble column bioreactors), Application (R&D, Bioproduction), End User (R&D department, Biopharmaceutical manufacturers) - Global Forecast to 2021" http://www.rnrmarketresearch.com/single-use-bioreactor-market-by-product-stem-cells-interferons-cell-yeast-plant-cells-technology-bubble-column-bioreactors-application-r-d-bioproduction-end-user-r-d-department-biopharmaceutical-man-st-to-2021-market-report.html

The global single-use bioreactors market is projected to reach USD 1,085.7 million by 2021 from USD 408.4 million in 2016, growing at a CAGR of 21.6% during the forecast period (2016–2021). In this report, the single-use bioreactors market is broadly segmented on the basis of product type, cell type, technology, application, end user, and region. Factors such as improved return on investment for small companies and startups, reduced complexity in automation, and positive impact on the environment are driving the growth of the single-use bioreactors market.

For a Sample copy of this report http://www.rnrmarketresearch.com/contacts/request-sample?rname=708352

On the basis of cell type, the single-use bioreactors market is categorized into mammalian cells, bacteria, yeast, and other cells (insect and plant cells). In 2016, the monoclonal antibodies segment is expected to account for the largest share of the single-use bioreactors market. Factors such as reduced risk of contamination and easy implementation in bioproduction are driving the adoption of SUBs for the production of these molecules. Based on technology, the single-use bioreactors market is categorized into wave-induced motion SUBs, stirred SUBs, single-use bubble column bioreactors, and others technologies. The wave-induced motion SUBs segment is expected to account for the largest market share in 2016. Growth in this segment can be attributed to the advantages offered by this technology such as high flexibility and shorter lead times.

Europe is expected to account for the largest share of the single-use bioreactors market in 2016. Patent cliff of many biologics drugs in Europe and government support for pharmaceutical companies to launch new biologics therapies with superior efficacy are driving the growth of the single-use bioreactors market in this region. The APAC single-use bioreactors market is expected to register the highest CAGR of 23.4% in the next five years. The rapidly growing health care industry and increasing investments by major pharmaceutical companies in this region are contributing to the high growth of the APAC single-use bioreactors market during the forecast period.

Avail Discount on this report http://www.rnrmarketresearch.com/contacts/discount?rname=708352

Product launches was the most widely adopted growth strategy pursued by players in the single-use bioreactors market, to increase their shares and cater to the unmet needs. The major players operating in the single-use bioreactors market include Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), GE Healthcare (U.S.), Danaher Corporation (U.S.), and Thermo Fisher Scientific Inc. (U.S.).

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the single-use bioreactors market. The report provides an analysis of the single-use bioreactors market, by product type, cell type, application, technology, end user, and region

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the single-use bioreactors market

Market Development: Comprehensive information about lucrative emerging markets. This report provides an analysis of the single-use bioreactors market across regions

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global single-use bioreactors market

Competitive Assessment: In-depth assessment of market strategies, product portfolios, and manufacturing capabilities of the leading players in the global single-use bioreactors market

Inquire about this report: http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=708352

RnRmarketresearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact:

Ritesh Tiwari

UNIT no 802, Tower no. 7, SEZ

Magarpatta city, Hadapsar

Pune - 411013

Maharashtra, India.

Tel:+1-888-391-5441

sales@ rnrmarketresearch.com